Prenetics (PRE) Global announced that it has completed the sale of its 3PL distribution business operated by its subsidiary, Europa Sports Partners. The all-stock transaction is valued at up to $13 million, subject to the achievement of certain performance milestones. This strategic divestiture allows Prenetics to further sharpen its focus on IM8, one of the world’s fastest-growing supplement brands, positioning the Company to drive long-term shareholder value by scaling IM8 globally. As IM8 continues to s ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Health Sciences company Prenetics Global Ltd. (NASDAQ:PRE) has said it is abandoning its Bitcoin treasury strategy. The David Beckham-backed company on Dec. 30 said it would no longer acquire Bitcoin and would instead focus on its supplement brand IM8. It cited the rapid growth of IM8, which it said had reached $100 million in annualized recurring revenue in just 11 months. Don't Miss: “The phenomenal su ...

Bitmain Co-Founders Caught in Billion-Dollar Fallout. Photo by BeInCrypto Prenetics Global Limited, the health sciences firm linked to David Beckham, said it will stop buying Bitcoin in 2026. This marks a clear retreat from the corporate Bitcoin treasury playbook that gained traction earlier in the cycle. The company confirmed it ended daily Bitcoin purchases in December 2025 and will not pursue further acquisitions. While Prenetics will retain its existing Bitcoin holdings, the strategic shift reflects a ...

Health science firm Prenetics Global, backed by football legend David Beckham, has stopped accumulating Bitcoin as of Dec 4. With an existing stash of 510 BTC, worth $45 million, and other cash equivalents, the company’s focus has pivoted to a nutrition supplement brand, IM8. Announced on Tuesday, Prenetics’ Board has unanimously agreed that the “most promising” way to create sustainable shareholder value is to devote to a “once-in-a-generation” brand like IM8. “Operating from a position of strength, we ...

Prenetics Global Limited (Nasdaq: PRE), a health sciences company with a Bitcoin (BTC) treasury, announced on Dec. 30 that it has ceased its daily Bitcoin purchasing activity as of Dec. 4. The company also announced that it will no longer acquire Bitcoin in the future following the approval by its Board of Directors. Prenetics is the parent of the IM8 premium consumer health brand co-founded by the English former football star David Beckham and championed by World No. 1 and four-time Grand Slam winner A ...

Prenetics (PRE), a health-sciences company that raised $48 million earlier this year, partially to build a bitcoin treasury, said it decided to stop purchasing BTC amid prolonged weakness in the cryptocurrency market. The company rolled out its bitcoin accumulation strategy in June, following a model championed by Michael Saylor’s Strategy Inc, in which firms raise capital to buy and hold crypto on their balance sheets. The business model gained traction earlier this year as crypto prices rose, but enthus ...

Company’s Capital and Strategic Focus Now Exclusively Focused on IM8 IM8 FY 2026 Revenue Projected to Reach $180 - $200 Million CHARLOTTE, N.C., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company, and parent of the IM8 premium health and longevity brand, today announced a strategic realignment to fully capitalize on the rapid growth of its consumer health brand, IM8. Prenetics ceased its daily Bitcoin purchasing activity ...

Prenetics Global Conference Summary Company Overview - **Company**: Prenetics Global (Ticker: PRE) - **Industry**: Consumer Healthcare, specifically in dietary supplements and diagnostics - **CEO**: Danny Young, co-founder since 2014 Key Points and Arguments Company Background and Growth - Prenetics started as a life sciences diagnostics testing company and pivoted to PCR testing during COVID, conducting over 28 million tests and generating $800 million in revenue over three years [2][3] - The company went public on NASDAQ in 2022 and is now positioned as the world's fastest-growing consumer healthcare brand [2] - Projected revenues for 2025 are approximately $90-$100 million, with expectations to reach $180-$200 million in 2026 driven by the IM8 brand [2][3] IM8 Brand - IM8 is a premium supplement brand co-founded with David Beckham, focusing on a scientific approach to health supplements [5][6] - The brand achieved $100 million in annual recurring revenue (ARR) within 11 months of launch, a record in the supplement industry [7][8] - Monthly revenue grew from $600,000 to $10 million over the past year, indicating strong growth momentum [8] - IM8 products are designed to simplify supplementation, offering multiple nutrients in a single powdered drink [10][11] Financial Metrics - The company has a strong balance sheet with approximately $70 million in cash and $117 million in total assets, including Bitcoin holdings [3][14] - The IM8 business is valued conservatively at $380 million, with a projected ARR run rate of $120 million [3][15] - The average order value increased from $110 to $145 after launching a new product, Daily Ultimate Longevity, indicating strong consumer demand [19] Market Position and Strategy - Prenetics operates in 41 countries, with a direct-to-consumer model that allows for better customer data utilization and marketing strategies [9][23] - The company plans to focus on two to three new product launches annually, maintaining a streamlined product line [18][19] - The management team emphasizes transparency and quality, with all products being NSF Certified for Sport and third-party tested [20] Divestment Strategy - Prenetics is divesting from legacy business units (Europa, CircleDNA, Insighta) to focus on the growth of IM8 [4][28][29] - The divestment of Insighta, valued at $70 million, is aimed at reallocating resources to enhance shareholder value [29] Bitcoin Strategy - The company initiated a Bitcoin treasury strategy to hedge against inflation, purchasing Bitcoin daily while maintaining a significant cash reserve [25][26] - The Bitcoin to cash ratio is expected to be around 30%-35%, ensuring operational liquidity [26] Competitive Landscape - Prenetics is positioned uniquely in the $700 billion global supplement market, with a focus on high-quality, scientifically-backed products [17][30] - The company believes it is undervalued in the market, trading at or slightly above cash and asset value, presenting a significant investment opportunity [30][31] Additional Insights - The company has received over 10,000 five-star reviews in just 11 months, indicating strong customer satisfaction [12] - High-profile endorsements from athletes like Aryna Sabalenka enhance brand visibility and credibility [12][21] - The management team has extensive experience in scaling businesses, which is crucial for navigating the competitive landscape [30] This summary encapsulates the key insights from the Prenetics Global conference, highlighting the company's growth trajectory, strategic focus, and market positioning.

Core Insights - Prenetics Global Limited will release its financial results for Q3 2025 on November 10, 2025, before market open, and will hold its first earnings conference call at 8:30 a.m. Eastern Time on the same day [1][2] Company Overview - Prenetics is a leading health sciences company focused on health and longevity, with its flagship consumer brand IM8 co-founded with David Beckham, which has achieved $100 million in annual recurring revenue within 11 months of launch, marking the fastest growth in the supplements industry [3] - The company has established a Bitcoin Treasury, purchasing 1 Bitcoin per day, totaling 382 BTC as of November 4, 2025, positioning itself at the intersection of health innovation and digital assets [4]

Core Insights - Prenetics Global Limited's IM8 brand achieved approximately $108 million in annualized recurring revenue (ARR) just 11 months post-launch, marking a significant milestone in its growth trajectory [1][4][9] - The company reported a record monthly revenue of $9 million in October, reflecting a 32% increase from September's $6.8 million, driven by strong subscriber growth and improved retention metrics [4][5] - Prenetics recently completed a $44 million equity offering, which is expected to facilitate accelerated global expansion and enhanced marketing initiatives [3][4] Financial Performance - IM8's monthly revenue reached $9 million in October, representing a 32% month-over-month growth from September [5] - The brand has delivered 13 million servings to over 420,000 customers across 31 countries since its launch [5] - IM8 projects a minimum of $10 million in monthly revenue by December 2025, with total revenues expected to be approximately $60 million for FY 2025 and between $180 million and $200 million for FY 2026 [12] Strategic Initiatives - The recent equity raise positions IM8 for aggressive scaling, including exploring partnerships with elite athletes and global wellness thought leaders [4][5] - The launch of the Daily Ultimate Longevity product has contributed to an increase in average order value from approximately $110 to $145, indicating strong consumer demand [5] - Prenetics aims to continue scaling IM8 through 2026 with initiatives focused on global distribution, product innovations, and retention efforts [8] Market Position - IM8 is recognized as the fastest-growing supplement brand globally, achieving $100 million in ARR within just 11 months of launch, surpassing previous records in the supplements industry [9] - The company is also pioneering in the intersection of health innovation and digital assets, having established a Bitcoin Treasury by purchasing 1 Bitcoin per day, totaling 380 BTC as of November 4, 2025 [10]